Menus Subscribe Search

Follow us


injection-needle

(PHOTO: JOLOEI/SHUTTERSTOCK)

The Cheaper, Bacteria-Derived Future of Drugs

• July 19, 2013 • 6:00 AM

(PHOTO: JOLOEI/SHUTTERSTOCK)

Drugs made from plants are often too expensive for the people who need them. A group of scientists may have found a solution.

The world is in dire need of cheap drugs to combat malaria. Malaria may seem like a disease from the distant past, but world-wide, it still exacts a large toll. Even worse, today’s malaria parasites are often resistant to the standard anti-malarial drugs. Newer and more effective drugs exist, but these drugs are well out of the price range of the patients in the developing world who need them.

Part of the problem is that the newer anti-malarial drugs come from plants. For thousands of years, humans have been getting their drugs from plants. While plants make a wide range of pharmacologically active compounds, they are not very practical: they can be difficult to cultivate in large quantities, their chemical yield can be unreliable, and the product we’re interested in can be expensive to isolate from other chemicals made by the plant. Add all that up and plant-derived drugs are too expensive for the people who need them. But there may be a solution: drugs made from bacteria (and other microbes).

Different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions.

The current source of newer anti-malarial drugs is Sweet Wormwood, a plant used in traditional Chinese medicine. The Chinese have long cultivated Sweet Wormwood, but the current world acreage of this plant is much less than we need. And even if there were enough Sweet Wormwood available, extracting the active ingredient, artemisinin, is an expensive and inefficient process.

To tackle this problem, the Bill and Melinda Gates Foundation funded a California-based group of industry and academic scientists to build a microbe that can crank out suitably large amounts of artemisinin (or artemisinic acid, a closely related chemical) while fermenting in an industrial-scale vat. The group recently reported success, which they achieved by making a variety of genetic modifications to ordinary baker’s yeast. The result is a yeast that makes artemisinic acid while fermenting sugar.

In the case of artemisinin-producing yeast, the researchers modified a natural yeast metabolic system, one that converts a chemical called Acetyl-CoA into a steroid. Acetyl-CoA is made by every organism on Earth, and is a precursor of many important biological molecules. The scientists made several genetic hacks to this metabolic system, resulting in a yeast strain whose enzyme levels can be fine-tuned by adding cheap chemicals to the yeasts’ nutrient broth. With the enzyme levels set just right, the yeasts’ Acetyl-CoA-to-steroid machinery gets highjacked to make large amounts of a chemical that is just a few enzymatic steps away from artemisinic acid.

The final genetic modification was to build in new enzymes that finish the job of making artemisinic acid. To do this, the researchers took a set of enzyme genes from Sweet Wormwood and transplanted them into the genome of their engineered yeast strain. The result: a yeast that feeds on sugar and pumps out artemisinic acid, at a fraction of the cost of extracting artemisinin from hectares of Sweet Wormwood.

The project involved substantial R&D, but principles can apply broadly. One reason why this kind of Wormwood-to-yeast metabolic engineering is successful is that the Wormwood enzymes involved are not very different from yeast enzymes that have other functions, making it possible for Wormwood enzymes to function in a yeast cell. In nature, there are many variations on a basic enzyme design; different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions. There is even a strain of bacteria (which evolved naturally in a contaminated military training range) whose enzymes break down explosives for food. The chemical repertoire of the natural world is tremendous. By harnessing that repertoire in microbial factories, we can make drugs, biofuels, and other chemicals in a way that has the potential to be cheaper, safer, and less damaging to the environment.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 24 • 4:00 PM

We Need to Normalize Drug Use in Our Society

After the disastrous misconceptions of the 20th century, we’re returning to the idea that drugs are an ordinary part of life experience and no more cause addiction than do other behaviors. This is rational and welcome.


October 24 • 2:00 PM

A Letter to the Next Attorney General: Fix Presidential Pardons

More than two years ago, a series showed that white applicants were far more likely to receive clemency than comparable applicants who were black. Since then, the government has spent hundreds of thousands of dollars on a study, but the pardons system remains unchanged.


October 24 • 12:00 PM

What Makes You So Smart, Middle School Math Teacher?

Noah Davis talks to Vern Williams about what makes middle school—yes, middle school—so great.


October 24 • 10:00 AM

Why DNA Is One of Humanity’s Greatest Inventions

How we’ve co-opted our genetic material to change our world.


October 24 • 8:00 AM

What Do Clowns Think of Clowns?

Three major players weigh in on the current state of the clown.


October 24 • 7:13 AM

There Is No Surge in Illegal Immigration

The overall rate of illegal immigration has actually decreased significantly in the last 10 years. The time is ripe for immigration reform.


October 24 • 6:15 AM

Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.


October 24 • 5:00 AM

Why We Gossip: It’s Really All About Ourselves

New research from the Netherlands finds stories we hear about others help us determine how we’re doing.


October 24 • 2:00 AM

Congratulations, Your City Is Dying!

Don’t take population numbers at face value.


October 23 • 4:00 PM

Of Course Marijuana Addiction Exists

The polarized legalization debate leads to exaggerated claims and denials about pot’s potential harms. The truth lies somewhere in between.


October 23 • 2:00 PM

American Companies Are Getting Way Too Cozy With the National Security Agency

Newly released documents describe “contractual relationships” between the NSA and U.S. companies, as well as undercover operatives.


October 23 • 12:00 PM

The Man Who’s Quantifying New York City

Noah Davis talks to the proprietor of I Quant NY. His methodology: a little something called “addition.”


October 23 • 11:02 AM

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.


October 23 • 10:00 AM

The Psychology of Bribery and Corruption

An FBI agent offered up confidential information about a political operative’s enemy in exchange for cash—and they both got caught. What were they thinking?


October 23 • 8:00 AM

Ebola News Gives Me a Guilty Thrill. Am I Crazy?

What it means to feel a little excited about the prospect of a horrific event.


October 23 • 7:04 AM

Why Don’t Men Read Romance Novels?

A lot of men just don’t read fiction, and if they do, structural misogyny drives them away from the genre.


October 23 • 6:00 AM

Why Do Americans Pray?

It depends on how you ask.


October 23 • 4:00 AM

Musicians Are Better Multitaskers

New research from Canada finds trained musicians more efficiently switch from one mental task to another.


October 22 • 4:00 PM

The Last Thing the Women’s Movement Needs Is a Heroic Male Takeover

Is the United Nations’ #HeForShe campaign helping feminism?


October 22 • 2:00 PM

Turning Public Education Into Private Profits

Baker Mitchell is a politically connected North Carolina businessman who celebrates the power of the free market. Every year, millions of public education dollars flow through Mitchell’s chain of four non-profit charter schools to for-profit companies he controls.


October 22 • 12:00 PM

Will the End of a Tax Loophole Kill Off Irish Business and Force Google and Apple to Pay Up?

U.S. technology giants have constructed international offices in Dublin in order to take advantage of favorable tax policies that are now changing. But Ireland might have enough other draws to keep them there even when costs climb.


October 22 • 10:00 AM

Veterans in the Ivory Tower

Why there aren’t enough veterans at America’s top schools—and what some people are trying to do to change that.


October 22 • 8:00 AM

Our Language Prejudices Don’t Make No Sense

We should embrace the fact that there’s no single recipe for English. Making fun of people for replacing “ask” with “aks,” or for frequently using double negatives just makes you look like the unsophisticated one.


October 22 • 7:04 AM

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.


October 22 • 6:00 AM

How We Form Our Routines

Whether it’s a morning cup of coffee or a glass of warm milk before bed, we all have our habitual processions. The way they become engrained, though, varies from person to person.


Follow us


Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.

That Cigarette Would Make a Great Water Filter

Clean out the ashtray, add some aluminum oxide, and you've (almost) got yourself a low-cost way to remove arsenic from drinking water.

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they're motivated by love while their enemies are motivated by hate.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.